MiRNA-93: a novel signature in human disorders and drug resistance

Mahmud Hussen, Bashdar and Rasool Abdullah, Snur and Fatih Rasul, Mohammed and Hassan Jawhar, Zanko and Sedeeq Hama Faraj, Goran and Kiani, Arda and Taheri, Mohammad (2023) MiRNA-93: a novel signature in human disorders and drug resistance. Cell Communication and Signaling, 21.

Text (Research Article) s12964-023-01106-3.pdf - Published Version Download (2MB)

Abstract

miRNA-93 is a member of the miR-106b-25 family and is encoded by a gene on chromosome 7q22.1. They play a role in the etiology of various diseases, including cancer, Parkinson’s disease, hepatic injury, osteoarthritis, acute myocardial infarction, atherosclerosis, rheumatoid arthritis, and chronic kidney disease. Different studies have found that this miRNA has opposing roles in the context of cancer. Recently, miRNA-93 has been downregulated in breast cancer, gastric cancer, colorectal cancer, pancreatic cancer, bladder cancer, cervical cancer, and renal cancer. However, miRNA-93 is up-regulated in a wide variety of malignancies, such as lung, colorectal, glioma, prostate, osteosarcoma, and hepatocellular carcinoma. The aim of the current review is to provide an overview of miRNA-93's function in cancer disorder progression and non-cancer disorders, with a focus on dysregulated signaling pathways. We also give an overview of this miRNA's function as a biomarker of prognosis in cancer and emphasize how it contributes to drug resistance based on in vivo, in vitro, and human studies.

Actions (login required)

View Item